Clinical Trial Update: A Two-Part Study to Determine: Best Medication Formulation and Food Effect [Phase 1]

View source ↗

Summary

Phase 1 two-part study by GlaxoSmithKline to determine the best medication formulation and food effect for an overactive bladder agent; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• GSK Investigational Compound (Overactive Bladder)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Overactive Bladder | Phase 1 | Status: COMPLETED